Omnia SanaPlant Comparison
Goldenseal vs Peppermint
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Goldenseal and Peppermint: they share 7 indicated uses (arthritis / joint pain, bloating, indigestion, …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Goldenseal | Peppermint | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 5/10 | 5/10 | Comparable evidence |
| Bloating | 5/10 | 5/10 | Comparable evidence |
| Indigestion | 5/10 | 5/10 | Comparable evidence |
| Infection (general) | 5/10 | 5/10 | Comparable evidence |
| Inflammation (general) | 5/10 | 5/10 | Comparable evidence |
| Skin irritation | 5/10 | 5/10 | Comparable evidence |
| Wounds | 5/10 | 5/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Berberine is the main antimicrobial, hypoglycaemic and hypolipidaemic constituent. Notably, whole-leaf extracts are more potent against MRSA than isolated berberine (owing to efflux-pump-inhibitory flavonoids) and show quorum-quenching, anti-virulence activity.
Menthol is the dominant constituent of the leaf oil, responsible for the cooling sensation and much of the antispasmodic and analgesic activity.
Phenolic antioxidants of the leaf.
Pharmacological Actions
Anti-inflammatory and astringent for inflamed mucous membranes (sore-throat gargle, mouth)
Antimicrobial (berberine) - supports skin, mucosal and gastrointestinal infections and sore throat
Anti-inflammatory and astringent for inflamed mucous membranes (sore-throat gargle, mouth)
Traditional & Indicated Uses
inferred from anti-inflammatory action
Digestive / gastrointestinal support (traditional for dyspepsia and ulcers)
Antimicrobial (berberine) - supports skin, mucosal and gastrointestinal infections and sore throat; Topical for skin infections and irritation - whole-leaf extract is active in vitro against methicillin-resistant Staphylococcus aureus (MRSA)
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Anti-inflammatory and astringent for inflamed mucous membranes (sore-throat gargle, mouth); Antimicrobial (berberine) - supports skin, mucosal and gastrointestinal infections and sore throat
inferred from anti-inflammatory action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from antispasmodic action
inferred from antispasmodic action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Contraindicated in pregnancy and breastfeeding: berberine crosses the placenta and into milk and can cause or worsen newborn jaundice (risk of kernicterus); do not give to infants.
Berberine strongly inhibits drug-metabolising enzymes (especially CYP3A4 and CYP2D6), so it can raise the blood levels of many medicines - a significant herb-drug-interaction risk. In a screen of commercial herbal products, goldenseal was among the most potent CYP2D6 inhibitors and also inhibited CYP3A4. High doses have shown possible liver, nerve and photo-toxicity.
Generally very safe. Essential oil should not be applied to the face or chest of infants or children — menthol can cause respiratory depression. Avoid enteric-coated capsules if taking antacids or acid-suppressing drugs. May worsen GERD by relaxing the lower oesophageal sphincter. Avoid in bile duct obstruction and gallstones.
Duke (2002) rates peppermint as +++ with clinical evidence (score 2) for antispasmodic activity, consistent with Commission E approval for IBS (irritable bowel syndrome) using enteric-coated peppermint oil capsules. Enteric-coated peppermint oil is one of the most clinically validated herbal treatments for IBS, reducing abdominal pain and spasm. Dose: 0.6 ml enteric-coated oil two to three times daily between meals (for IBS); 1.5–3 g dried leaf as tea three times daily for digestive complaints. Peppermint should not be applied near the face or nostrils of infants and small children (risk of laryngospasm from menthol). Contraindicated in cholelithiasis (gallstones) (Duke, 2002).
External Ids
Botanical Description
Low, woodland perennial herb rising from a knotted, bright yellow rhizome with wiry yellow roots. Each stem bears two ragged, palmately lobed, maple-like leaves and a single small, inconspicuous greenish-white flower, followed by a raspberry-like cluster of red berries.[1]
Perennial herb, 30-90 cm tall, a sterile natural hybrid (Mentha aquatica x M. spicata) that spreads by rhizomes and surface stolons rather than viable seed. Stems are square, often purple-tinged. Leaves are opposite, lance-shaped to ovate with a sharply toothed margin, and release a strong menthol scent when crushed. Small, pale purple flowers are borne in dense, interrupted terminal spikes.[2]
Habitat
Grows in rich, shaded deciduous woodland with humus-rich soil; native to eastern North America, now scarce in the wild due to overharvesting and largely supplied by cultivation.[1]
A cultivated hybrid grown worldwide as a crop and garden herb, propagated vegetatively since it rarely sets viable seed; naturalised in damp ground - streambanks, ditches and waste places - in temperate regions.[2]
Harvesting
The rhizome and root are dug in autumn from plants at least three to four years old, when berberine content is highest, then cleaned and dried; because wild populations are depleted, cultivated or sustainably sourced material is strongly preferred, and careful identification against the toxic mayapple and bloodroot, which share its woodland habitat, is essential before any wild-harvesting.[1]
Aerial parts are cut at or just before full flowering (mid- to late summer), when the essential-oil (menthol) content peaks, then dried quickly out of direct sun, or distilled fresh for essential oil.[3]
Traditional Uses
Goldenseal root has a Native American and, after adoption by Eclectic physicians, wider North American tradition as a bitter tonic and antimicrobial remedy for mucous-membrane infections, sore throat, digestive upset and topical skin infections, directly reflecting its high berberine content.[1]
Peppermint has one of the best-documented traditional uses of any herb - as a carminative and antispasmodic for indigestion, bloating and colic. Enteric-coated peppermint oil capsules are among the most clinically validated herbal treatments for irritable bowel syndrome, and topical or inhaled peppermint oil is traditionally and clinically used for tension-type headache and muscular aches.[1, 2, 4, 5]
Preparations
Dried rhizome and root simmered in water as a traditional bitter antimicrobial tea, or used as a gargle for sore throat.
Tincture 1:10 in 60% ethanol of the dried rhizome and root, 2-4 ml three times daily per the WHO monograph Rhizoma Hydrastis. Educational reference only, not a prescription.
Extract standardised to berberine/hydrastine content, taken as capsules; whole-leaf extracts have shown stronger antimicrobial activity than isolated berberine in some studies.
Dried leaf steeped in hot water, the classic digestive tea.
Standardised peppermint oil in enteric-coated capsules, the clinically studied form for irritable bowel syndrome, releasing the oil in the intestine rather than the stomach.
Diluted essential oil applied to the temples and neck for tension-type headache.
Dosage
The WHO monograph on Rhizoma Hydrastis gives a daily dose of 0.5-1.0 g of the dried rhizome and root three times, or taken as a decoction; a 1:1 liquid extract in 60% ethanol at 0.3-1.0 mL three times; or a 1:10 tincture in 60% ethanol at 2-4 mL three times. For short-term use only, given goldenseal's potent CYP-enzyme inhibition and its contraindication in pregnancy. Educational reference only, not a prescription.
Duke (2002) and Commission E guidance: about 0.6 mL enteric-coated oil two to three times daily between meals for IBS-type digestive complaints. Educational reference only, not a prescription.
References
Drug Class Interactions
Not documented
Lookalikes Review
Dangerous Lookalikes
Not documented
References & Sources
- Mandal, S.K., Maji, A.K., Mishra, S.K., Ishfaq, P.M., Devkota, H.P., Silva, A.S. and Das, N (2020) 'Goldenseal (Hydrastis canadensis L.) and its active constituents: A critical review of their efficacy and toxicological issues', Pharmacological Research. doi:10.1016/j.phrs.2020.105085 Randomized trial
https://doi.org/10.1016/j.phrs.2020.105085 - Corn, J., Tibbitts, D., Ito, H., Schafer, M. and Vasilevsky, N (2021) 'Effects of Hydrastis Canadensis, Commiphora Habessinica, Phytolacca Americana, and Echinacea Purpurea on Bacterial Growth', Alternative Therapies in Health and Medicine, 27(4), pp. 24-27. Preclinical
https://scholar.google.com/scholar?q=Effects%20of%20Hydrastis%20Canadensis%2C%20Commiphora%20Habessinica%2C%20Phytolacca%20Americana%2C%20and%20Echinacea%20Purpurea%20on%20Bacterial%20Growth - Ettefagh, K.A., Burns, J.T., Junio, H.A., Kaatz, G.W. and Cech, N.B (2010) 'Goldenseal (Hydrastis canadensis L.) extracts synergistically enhance the antibacterial activity of berberine via efflux pump inhibition', Planta Medica, 77(8), pp. 835-840. doi:10.1055/s-0030-1250606 Preclinical
https://doi.org/10.1055/s-0030-1250606 - Cech, N.B., Junio, H.A., Ackermann, L.W., Kavanaugh, J.S. and Horswill, A.R (2012) 'Quorum quenching and antimicrobial activity of goldenseal (Hydrastis canadensis) against methicillin-resistant Staphylococcus aureus (MRSA)', Planta Medica, 78(14), pp. 1556--1561. doi:10.1055/s-0032-1315042 Traditional / reference
https://doi.org/10.1055/s-0032-1315042 - Mahady, G.B., Pendland, S.L., Stoia, A. and Chadwick, L.R (2003) 'In vitro susceptibility of Helicobacter pylori to isoquinoline alkaloids from Sanguinaria canadensis and Hydrastis canadensis', Phytotherapy Research, 17(3), pp. 217-221. doi:10.1002/ptr.1108 Preclinical
https://doi.org/10.1002/ptr.1108 - Junio, H.A., Sy-Cordero, A.A., Ettefagh, K.A., Burns, J.T., Micko, K.T., Graf, T.N., Richter, S.J., Cannon, R.E., Oberlies, N.H. and Cech, N.B (2011) 'Synergy-directed fractionation of botanical medicines: a case study with goldenseal (Hydrastis canadensis)', Journal of Natural Products, 74(7), pp. 1621-1629. doi:10.1021/np200336g Preclinical
https://doi.org/10.1021/np200336g - Britton, E.R., Kellogg, J.J., Kvalheim, O.M. and Cech, N.B (2017) 'Biochemometrics to Identify Synergists and Additives from Botanical Medicines: A Case Study with Hydrastis canadensis (Goldenseal)', Journal of Natural Products, 81(3), pp. 484-493. doi:10.1021/acs.jnatprod.7b00654 Preclinical
https://doi.org/10.1021/acs.jnatprod.7b00654 - Leyte-Lugo, M., Britton, E.R., Foil, D.H., Brown, A.R., Todd, D.A., Rivera-Chavez, J., Oberlies, N.H. and Cech, N.B (2017) 'Secondary Metabolites from the Leaves of the Medicinal Plant Goldenseal (Hydrastis canadensis)', Phytochemistry Letters, 20, pp. 54-60. doi:10.1016/j.phytol.2017.03.012 Preclinical
https://doi.org/10.1016/j.phytol.2017.03.012 - Gurley, B.J., Swain, A., Hubbard, M.A., Hartsfield, F., Thaden, J., Williams, D.K., Gentry, W.B. and Tong, Y (2007) 'Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo', Clinical Pharmacology and Therapeutics, 83(1), pp. 61-69. doi:10.1038/sj.clpt.6100222 Randomized trial
https://doi.org/10.1038/sj.clpt.6100222 - Wallace, E.D., Oberlies, N.H., Cech, N.B. and Kellogg, J.J (2018) 'Detection of adulteration in Hydrastis canadensis (goldenseal) dietary supplements via untargeted mass spectrometry-based metabolomics', Food and Chemical Toxicology, 120, pp. 439-447. doi:10.1016/j.fct.2018.07.033 Preclinical
https://doi.org/10.1016/j.fct.2018.07.033 - Douglas, J.A., Follett, J.M., Parmenter, G.A., Sansom, C.E., Perry, N.B. and Littler, R.A (2010) 'Seasonal variation of biomass and bioactive alkaloid content of goldenseal, Hydrastis canadensis', Fitoterapia, 81(7), pp. 925-928. doi:10.1016/j.fitote.2010.06.006 Preclinical
https://doi.org/10.1016/j.fitote.2010.06.006 - Singh, S., Pathak, N., Fatima, E. and Negi, A.S (2021) 'Plant isoquinoline alkaloids: Advances in the chemistry and biology of berberine', European Journal of Medicinal Chemistry. doi:10.1016/j.ejmech.2021.113839 Preclinical
https://doi.org/10.1016/j.ejmech.2021.113839 - World Health Organization (2007) 'Rhizoma Hydrastis'. Available at: https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 Traditional / reference
https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 - Sevior, D.K., Hokkanen, J., Tolonen, A., Abass, K., Tursas, L., Pelkonen, O. and Ahokas, J.T (2010) 'Rapid screening of commercially available herbal products for the inhibition of major human hepatic cytochrome P450 enzymes using the N-in-one cocktail', Xenobiotica, 40(4), pp. 245--254. doi:10.3109/00498251003592683 Preclinical
https://doi.org/10.3109/00498251003592683 - Gurley, B.J., Gardner, S.F., Hubbard, M.A., Williams, D.K., Gentry, W.B., Khan, I.A. and Shah, A (2005) 'In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes', Clinical Pharmacology and Therapeutics, 77(5), pp. 415-426. doi:10.1016/j.clpt.2005.01.009 Randomized trial
https://doi.org/10.1016/j.clpt.2005.01.009 - McDonald, M.G., Tian, D.D., Thummel, K.E., Paine, M.F. and Rettie, A.E (2020) 'Modulation of major human liver microsomal cytochromes P450 by component alkaloids of goldenseal: time-dependent inhibition and allosteric effects', Drug Metabolism and Disposition, 48(10), pp. 1018-1027. doi:10.1124/dmd.120.091041 Preclinical
https://doi.org/10.1124/dmd.120.091041 - Guo, J., Chen, H., Zhang, X., Lou, W., Zhang, P., Qiu, Y., Zhang, C., Wang, Y. and Liu, W.J (2021) 'The effect of berberine on metabolic profiles in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials', Oxidative Medicine and Cellular Longevity, 2021, pp. 2074610. doi:10.1155/2021/2074610 Meta-analysis / review
https://doi.org/10.1155/2021/2074610 - Forest Farming (Cooperative Extension) 'Goldenseal (Hydrastis canadensis L.)'. Available at: https://forest-farming.extension.org/goldenseal-hydrastis-canadensis-l/ Traditional / reference
https://forest-farming.extension.org/goldenseal-hydrastis-canadensis-l/ - Frasca, T. and Brett, A.S. and Yoo, S.D (1997) 'Mandrake toxicity. A case of mistaken identity', Archives of Internal Medicine, 157(17), pp. 2007-9. doi:10.1001/archinte.157.17.2007 Clinical study
https://doi.org/10.1001/archinte.157.17.2007 - North Carolina Extension Gardener Plant Toolbox 'Sanguinaria canadensis (Bloodroot)'. Available at: https://plants.ces.ncsu.edu/plants/sanguinaria-canadensis/ Traditional / reference
https://plants.ces.ncsu.edu/plants/sanguinaria-canadensis/
- McKay, D.L. and Blumberg, J.B (2006) 'A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.)', Phytotherapy Research, 20(8), pp. 619-633. doi:10.1002/ptr.1936 Meta-analysis / review
https://doi.org/10.1002/ptr.1936 - Mahendran, G. and Rahman, L.U (2020) 'Ethnomedicinal, phytochemical and pharmacological updates on Peppermint (Mentha x piperita L.)-A review', Phytotherapy Research, 34(9), pp. 2088-2139. doi:10.1002/ptr.6664 Meta-analysis / review
https://doi.org/10.1002/ptr.6664 - Zhao, H., Ren, S., Yang, H., Tang, S. and others (2022) 'Peppermint essential oil: its phytochemistry, biological activity, pharmacological effect and application', Biomedicine & Pharmacotherapy, 154, pp. 113559. doi:10.1016/j.biopha.2022.113559 Meta-analysis / review
https://doi.org/10.1016/j.biopha.2022.113559 - Keifer, D., Ulbricht, C., Abrams, T.R., Basch, E. and others (2007) 'Peppermint (Mentha piperita): an evidence-based systematic review by the Natural Standard Research Collaboration', Journal of Herbal Pharmacotherapy, 7(2), pp. 91-143. doi:10.1300/j157v07n02_07 Meta-analysis / review
https://doi.org/10.1300/j157v07n02_07 - Gobel, H., Heinze, A., Heinze-Kuhn, K., Gobel, A. and Gobel, C (2016) 'Peppermint oil in the acute treatment of tension-type headache', Schmerz, 30(3), pp. 295-310. doi:10.1007/s00482-016-0109-6 Meta-analysis / review
https://doi.org/10.1007/s00482-016-0109-6 - Nair, B (2001) 'Final report on the safety assessment of Mentha Piperita (Peppermint) Oil, Mentha Piperita (Peppermint) Leaf Extract, Mentha Piperita (Peppermint) Leaf, and Mentha Piperita (Peppermint) Leaf Water', International Journal of Toxicology, 20(Suppl 3), pp. 61-73. doi:10.1080/10915810152902592 Meta-analysis / review
https://doi.org/10.1080/10915810152902592 - Kobayashi, T., Sugaya, K., Onose, J. and Abe, N (2019) 'Peppermint (Mentha piperita) extract effectively inhibits cytochrome P450 3A4 (CYP3A4) mRNA induction in rifampicin-treated HepG2 cells', Bioscience, Biotechnology, and Biochemistry, 83(7), pp. 1181-1192. doi:10.1080/09168451.2019.1608802 Preclinical
https://doi.org/10.1080/09168451.2019.1608802 - Romero, M.C., Navarro, M.C., Martin-Sanchez, J. and Valero, A (2014) 'Peppermint (Mentha piperita) and albendazole against anisakiasis in an animal model', Tropical Medicine & International Health, 19(12), pp. 1430-1436. doi:10.1111/tmi.12399 Preclinical
https://doi.org/10.1111/tmi.12399 - Riachi, L.G. and De Maria, C.A.B (2015) 'Peppermint antioxidants revisited', Food Chemistry, 176, pp. 72-81. doi:10.1016/j.foodchem.2014.12.028 Meta-analysis / review
https://doi.org/10.1016/j.foodchem.2014.12.028 - Herro, E. and Jacob, S.E (2010) 'Mentha piperita (peppermint)', Dermatitis, 21(6), pp. 327-329. doi:10.2310/6620.2011.10080 Preclinical
https://doi.org/10.2310/6620.2011.10080 - Sun, Z. and Wang, H. and Wang, J. and Zhou, L. and Yang, P (2014) 'Chemical Composition and Anti-Inflammatory, Cytotoxic and Antioxidant Activities of Essential Oil from Leaves of Mentha piperita Grown in China', PLoS ONE. doi:10.1371/journal.pone.0114767 Preclinical
https://doi.org/10.1371/journal.pone.0114767 - Farco, J.A. and Grundmann, O (2012) 'Menthol - Pharmacology of an Important Naturally Medicinal “Cool”', Mini-Reviews in Medicinal Chemistry. doi:10.2174/138955713804484686 Preclinical
https://doi.org/10.2174/138955713804484686 - Geuenich, S. and Goffinet, C. and Venzke, S. and Nolkemper, S. and Baumann, I. and Plinkert, P.K. and Reichling, J. and Keppler, O.T (2008) 'Aqueous extracts from peppermint, sage and lemon balm leaves display potent anti-HIV-1 activity by increasing the virion density', Retrovirology. doi:10.1186/1742-4690-5-27 Preclinical
https://doi.org/10.1186/1742-4690-5-27 - Nolkemper, S. and Reichling, J. and Stintzing, F.C. and Carle, R. and Schnitzler, P (2006) 'Antiviral Effect of Aqueous Extracts from Species of the Lamiaceae Family against Herpes simplex Virus Type 1 and Type 2 in vitro', Planta Medica. doi:10.1055/s-2006-951719 Preclinical
https://doi.org/10.1055/s-2006-951719 - Mahady, G.B. and Pendland, S.L. and Stoia, A. and Hamill, F.A. and Fabricant, D.G. and Dietz, B.M. and Chadwick, L.R (2005) 'In Vitro susceptibility ofHelicobacter pylori to botanical extracts used traditionally for the treatment of gastrointestinal disorders', Phytotherapy Research. doi:10.1002/ptr.1776 Preclinical
https://doi.org/10.1002/ptr.1776 - Tullio, V.C. and Roana, J. and Scalas, D. and Mandras, N (2019) 'Evaluation of the Antifungal Activity of Mentha x piperita (Lamiaceae) of Pancalieri (Turin, Italy) Essential Oil and Its Synergistic Interaction with Azoles', Molecules. doi:10.3390/molecules24173148 Preclinical
https://doi.org/10.3390/molecules24173148 - Neves, A. and Rosa, S. and Gonçalves, J. and Rufino, A.T. and Judas, F. and Salgueiro, L. and Lopes, M.C. and Cavaleiro, C. and Mendes, A (2009) 'Screening of Five Essential Oils for Identification of Potential Inhibitors of IL-1-induced Nf-κB Activation and NO Production in Human Chondrocytes: Characterization of the Inhibitory Activity ofα-Pinene', Planta Medica. doi:10.1055/s-0029-1186085 Preclinical
https://doi.org/10.1055/s-0029-1186085 - Wu, Z. and Tan, B. and Liu, Y. and Dunn, J.L. and Guerola, P.M. and Tortajada, M. and Cao, Z. and Ji, P (2019) 'Chemical Composition and Antioxidant Properties of Essential Oils from Peppermint, Native Spearmint and Scotch Spearmint', Molecules. doi:10.3390/molecules24152825 Preclinical
https://doi.org/10.3390/molecules24152825 - Bojić, M. and Maleš, Ž. and Antolić, A. and Babić, I. and Tomičić, M (2019) 'Antithrombotic activity of flavonoids and polyphenols rich plant species', Acta Pharmaceutica. doi:10.2478/acph-2019-0050 Preclinical
https://doi.org/10.2478/acph-2019-0050 - Dorman, H.J.D. and Koşar, M. and Kahlos, K. and Holm, Y. and Hiltunen, R (2003) 'Antioxidant Properties and Composition of Aqueous Extracts from Mentha Species, Hybrids, Varieties, and Cultivars', Journal of Agricultural and Food Chemistry. doi:10.1021/jf034108k Preclinical
https://doi.org/10.1021/jf034108k - Benabdallah, A. and Boumendjel, M. and Aissi, O. and Rahmoune, C. and Boussaïd, M. and Messaoud, C (2018) 'Chemical composition, antioxidant activity and acetylcholinesterase inhibitory of wild Mentha species from northeastern Algeria', South African Journal of Botany. doi:10.1016/j.sajb.2018.03.002 Preclinical
https://doi.org/10.1016/j.sajb.2018.03.002 - Ayaz, M. and Sadiq, A. and Junaid, M. and Ullah, F. and Subhan, F. and Ahmed, J (2017) 'Neuroprotective and Anti-Aging Potentials of Essential Oils from Aromatic and Medicinal Plants', Frontiers in Aging Neuroscience. doi:10.3389/fnagi.2017.00168 Clinical study
https://doi.org/10.3389/fnagi.2017.00168 - Vladimir‐Knežević, S. and Blažeković, B. and Kindl, M. and Vladić, J. and Lower-Nedza, A.D. and Brantner, A (2014) 'Acetylcholinesterase Inhibitory, Antioxidant and Phytochemical Properties of Selected Medicinal Plants of the Lamiaceae Family', Molecules. doi:10.3390/molecules19010767 Preclinical
https://doi.org/10.3390/molecules19010767 - López, V. and Martin, S.D. and Gómez‐Serranillos, M.P. and Carretero, M. and Jäger, A.K. and Calvo, M.I (2009) 'Neuroprotective and neurochemical properties of mint extracts', Phytotherapy Research. doi:10.1002/ptr.3037 Preclinical
https://doi.org/10.1002/ptr.3037 - Orhan, İ.E. and Kartal, M. and Kan, Y. and Şener, B (2008) 'Activity of Essential Oils and Individual Components against Acetyland Butyrylcholinesterase', Zeitschrift für Naturforschung C. doi:10.1515/znc-2008-7-813 Preclinical
https://doi.org/10.1515/znc-2008-7-813 - Zeljkovıć, S.Ć. and Šišková, J. and Komzáková, K. and Diego, N.D. and Kaffková, K. and Tarkowski, P (2021) 'Phenolic Compounds and Biological Activity of Selected Mentha Species', Plants. doi:10.3390/plants10030550 Preclinical
https://doi.org/10.3390/plants10030550 - Desam, N.R. and Al-Rajab, A.J. and Sharma, M. and Mylabathula, M.M. and Gowkanapalli, R.R. and Albratty, M (2017) 'Chemical constituents, in vitro antibacterial and antifungal activity of Mentha×Piperita L. (peppermint) essential oils', Journal of King Saud University - Science. doi:10.1016/j.jksus.2017.07.013 Preclinical
https://doi.org/10.1016/j.jksus.2017.07.013 - Husain, F.M. and Ahmad, I. and Khan, M.S. and Ahmad, E. and Tahseen, Q. and Khan, M.S. and Al‐Shabib, N.A (2015) 'Sub-MICs of Mentha piperita essential oil and menthol inhibits AHL mediated quorum sensing and biofilm of Gram-negative bacteria', Frontiers in Microbiology. doi:10.3389/fmicb.2015.00420 Preclinical
https://doi.org/10.3389/fmicb.2015.00420 - Khayyal, M.T. and El‐Ghazaly, M.A. and Kenawy, S.A. and Seif-El-Nasr, M. and Mahran, L. and Kafafi, Y. and Okpanyi, S (2011) 'Antiulcerogenic Effect of Some Gastrointestinally Acting Plant Extracts and their Combination', Arzneimittelforschung. doi:10.1055/s-0031-1300078 Preclinical
https://doi.org/10.1055/s-0031-1300078 - Singh, R. and Shushni, M.A.M. and Belkheir, A.K (2011) 'Antibacterial and antioxidant activities of Mentha piperita L', Arabian Journal of Chemistry. doi:10.1016/j.arabjc.2011.01.019 Preclinical
https://doi.org/10.1016/j.arabjc.2011.01.019 - Dorman, H.J.D. and Koşar, M. and Başer, K.H.C. and Hiltunen, R (2009) 'Phenolic Profile and Antioxidant Evaluation of Mentha x Piperita L. (Peppermint) Extracts', Natural Product Communications. doi:10.1177/1934578x0900400419 Preclinical
https://doi.org/10.1177/1934578x0900400419 - İşcan, G. and Kırımer, N. and Kürkçüoğlu, M. and Başer, H.C. and Demi̇rci̇, F (2002) 'Antimicrobial Screening of Mentha piperita Essential Oils', Journal of Agricultural and Food Chemistry. doi:10.1021/jf011476k Preclinical
https://doi.org/10.1021/jf011476k - Akdogan, M. et al (2004) 'Investigation of biochemical and histopathological effects of Mentha piperita labiatae and Mentha spicata labiatae on kidney tissue in rats', 23(7), pp. 321--327. Preclinical
https://scholar.google.com/scholar?q=Investigation%20of%20biochemical%20and%20histopathological%20effects%20of%20Mentha%20piperita%20labiatae%20and%20Mentha%20spicata%20labiatae%20on%20kidney%20tissue%20in%20rats - Grigoleit, H.G. and Grigoleit, P (2005) 'Peppermint oil in irritable bowel syndrome', 12(8), pp. 601--606. Randomized trial
https://scholar.google.com/scholar?q=Peppermint%20oil%20in%20irritable%20bowel%20syndrome - Mas-Coma, S (2004) 'Fasciolosis in humans'. Traditional / reference
https://scholar.google.com/scholar?q=Fasciolosis%20in%20humans - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.